Evaluating disparities in allogeneic transplantation based on ancestry and socio-economic status

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess how a patient's ancestry and socio-economic status influence their choice of donor cells for allogeneic bone marrow transplantation. It will evaluate various factors including the time to transplant, treatment-related mortality, and overall survival rates for candidates at MD Anderson Cancer Center. The study will utilize patient ancestry questionnaires to gather relevant data and analyze the impact of these factors on the transplantation process.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. ≥ 18 years of age.
2. Candidate for allogeneic transplantation

Exclusion Criteria:

1\) Allogeneic stem cell transplantation not medically indicated.

Where it's running

• MD Anderson Cancer Center
  Houston, Texas, United States Recruiting

Study contacts

• Principal investigator: Warren Fingrut, MD — M.D. Anderson Cancer Center
• Study coordinator: Warren Fingrut, MD
• Email: wbfingrut@mdanderson.org
• Phone: (832) 387-8363

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Improving outcomes for older patients receiving allogeneic transplants through exercise

  This study is testing if a supervised exercise program can help older adults recover better after receiving a stem cell transplant.

  Recruiting Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania · NCT05612789

• Preventing heart problems in overweight/obese young sarcoma survivors with tirzepatide

  This feasibility study tests whether tirzepatide can be safely given to overweight or obese young adults (18–39) who have completed doxorubicin for soft tissue or bone sarcoma to see if it’s feasible to use in the first year after therapy.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT07874828

• Predicting lymphedema risk in inflammatory breast cancer patients using preoperative body impedance analysis

  This study tests whether a preoperative bioimpedance test can help identify IBC patients who are at risk for developing lymphedema.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07855627

• Precision genomic testing to guide first-line LBCL treatment readiness

  Doctors will see if a tumor genomic test can help tailor first-line treatment for adults with LBCL by the start of the second cycle of standard therapy.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07829445

• Using Apple Vision Pro in image-guided procedures

  This study tests whether the Apple Vision Pro can be used during CT-guided biopsy procedures to help with imaging and guidance.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07819513

• Geniculate Artery Embolization for Knee Osteoarthritis in Cancer Patients

  This study tests whether blocking knee blood vessels with a standard care procedure can help reduce pain and improve function in people with knee osteoarthritis who also have cancer.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07807943

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.